CanSino Biologics (SEHK: 6185)
HK$18.06
(-1.8%)
-HK$0.34
Price as of April 24, 2024, 12:08 p.m. ET
CanSino Biologics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CanSino Biologics Company Info
Chinese Vaccine producer
News & Analysis
Featured Article
Here's Your Guide to the Coronavirus Vaccine Leaders
Let's take a look at what's happened so far and what's on the horizon.
Adria Cimino | Jul 26, 2020
Featured Article
CanSino's COVID-19 Vaccine Was Just Approved for Limited Use in China. Here's What Investors Should Know.
Underwhelming vaccine efficacy makes for unenthusiastic stock growth.
Alex Carchidi | Jul 7, 2020
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.